Related references
Note: Only part of the references are listed.Molecular alterations contributing to pancreatic cancer chemoresistance
Azam Rajabpour et al.
PANCREATOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
Andrea Mari et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Xiaoming Liu et al.
CURRENT CANCER DRUG TARGETS (2016)
Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective
Lisa Gherardini et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
Sofia Torres et al.
CLINICAL CANCER RESEARCH (2015)
Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
Kevin M. Elias et al.
GYNECOLOGIC ONCOLOGY (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
Chun-Wei Chen et al.
NATURE MEDICINE (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
Bowen Xu et al.
BLOOD (2015)
Cancer: Evolution Within a Lifetime
Marco Gerlinger et al.
ANNUAL REVIEW OF GENETICS, VOL 48 (2014)
Sine oculis homeobox homolog 1 promotes α5β1-mediated invasive migration and metastasis of cervical cancer cells
Dan Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
AmrZ is a global transcriptional regulator implicated in iron uptake and environmental adaption in P. fluorescens F113
Francisco Martinez-Granero et al.
BMC GENOMICS (2014)
AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes
Aniruddha J. Deshpande et al.
CANCER CELL (2014)
SIX1 Promotes Tumor Lymphangiogenesis by Coordinating TGFβ Signals That Increase Expression of VEGF-C
Dan Liu et al.
CANCER RESEARCH (2014)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
Bryan Oronsky et al.
TRANSLATIONAL ONCOLOGY (2014)
Epigenetic mechanisms of importance for drug treatment
Maxim Ivanov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Histones and their modifications in ovarian cancer-drivers of disease and therapeutic targets
Deborah J. Marsh et al.
FRONTIERS IN ONCOLOGY (2014)
Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic stress
Veslemoy Rolseth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage
Yuwen Li et al.
CELLULAR SIGNALLING (2013)
A regulatory role for the cohesin loader NIPBL in nonhomologous end joining during immunoglobulin class switch recombination
Elin Enervald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Chaoyang Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas (Review)
Li Xiang et al.
ONCOLOGY LETTERS (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
Benjamin Frederick Ganzfried et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2013)
Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment
Jeremy Chien et al.
FRONTIERS IN ONCOLOGY (2013)
Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage
Rene Huber et al.
CELLULAR SIGNALLING (2012)
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
Stephen G. Landt et al.
GENOME RESEARCH (2012)
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression
Lingbao Ai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
The nucleoporin 153, a novel factor in double-strand break repair and DNA damage response
C. Lemaitre et al.
ONCOGENE (2012)
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
C. Zeller et al.
ONCOGENE (2012)
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Jaeyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP
Wei Wang et al.
APOPTOSIS (2011)
The diverse functions of Dot1 and H3K79 methylation
Anh Tram Nguyen et al.
GENES & DEVELOPMENT (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
Sha Hu et al.
CANCER BIOLOGY & THERAPY (2010)
Rapamycin and the transcription factor C/EBP beta as a switch in osteoclast differentiation: implications for lytic bone diseases
Jeske J. Smink et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
Elizabeth M. Freeburg et al.
CANCER CELL INTERNATIONAL (2009)
RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins
Carsten Doil et al.
CELL (2009)
CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases
Cynthia A. Zahnow
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis
Hye-Jung Han et al.
NATURE (2008)
Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark
Alexander J. Ruthenburg et al.
MOLECULAR CELL (2007)
Genomic alterations in lobular neoplasia: A microarray comparative genomic hybridization signature for early neoplastic proliferation in the breast
Teresa L. Mastracci et al.
GENES CHROMOSOMES & CANCER (2006)
Epigenetics as a mechanism driving polygenic clinical drug resistance
RM Glasspool et al.
BRITISH JOURNAL OF CANCER (2006)
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
Trevor G. Shepherd et al.
NATURE PROTOCOLS (2006)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
C/EBPβ cooperates with RB:E2F to implement RasV12-induced cellular senescence
T Sebastian et al.
EMBO JOURNAL (2005)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin
JD Seidman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Share Paper
